Confronting Cancer as a Community

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Procedure, Other
Study Type: Observational
SUMMARY

This study aims to better understand the cause of colorectal cancer and how to find the best treatment for Hispanic patients with colorectal cancer. The genetic information in the blood and tissues may explain why patients who have the same type of cancer and receive the same treatment do not always have the same results. By combining genetic (certain qualities or traits passed from parents to offspring) information with clinical data, such as the responses of different kinds of cancers to different treatments, this study could lead to more knowledge about why certain cancers occur and why they respond differently to treatments. Information gathered from this study may help researchers match treatments to the genetics of each patient and the genetic changes in their tumor. This approach is known as personalized medicine.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Self-reported Hispanic ethnicity

• Diagnosed with colon or rectal cancer (at any time and stage; lifetime diagnosis and in survival are eligible)

• Has a tumor tissue sample archived or plans to have tissue archived from a standard care procedure

• Age \>= 18 years

Locations
United States
California
Los Angeles County-USC Medical Center
RECRUITING
Los Angeles
USC / Norris Comprehensive Cancer Center
RECRUITING
Los Angeles
Contact Information
Primary
Ashley Noriega
Ashley.Noriega@med.usc.edu
323-865-3000
Time Frame
Start Date: 2022-05-25
Estimated Completion Date: 2028-05-25
Participants
Target number of participants: 500
Treatments
Observational (stool, blood, tissue, genetic testing, questionnaires)
Patients undergo stool sample collection, blood sample collection, collection of archival tumor tissue and genetic testing, and complete questionnaires on study. Patients also have their medical records reviewed on study.
Sponsors
Leads: University of Southern California
Collaborators: National Cancer Institute (NCI)

This content was sourced from clinicaltrials.gov